{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:58:11Z","timestamp":1789351091529,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-11-EMCO-012-02 TDE"],"award-info":[{"award-number":["ANR-11-EMCO-012-02 TDE"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union 7th Framework Program","award":["FP7\/2012"],"award-info":[{"award-number":["FP7\/2012"]}]},{"name":"SWITCH-HD","award":["324495"],"award-info":[{"award-number":["324495"]}]},{"name":"Egide grant (PHC Procope grant","award":["26747RM"],"award-info":[{"award-number":["26747RM"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neuropharm.2017.05.032","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T18:46:27Z","timestamp":1496515587000},"page":"136-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Altered reactivity of central amygdala to GABAAR antagonist in the BACHD rat model of Huntington disease"],"prefix":"10.1016","volume":"123","author":[{"given":"Charlotte","family":"Lamirault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Yu-Taeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Doy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"El Massioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.05.032_bib1","doi-asserted-by":"crossref","first-page":"e71633","DOI":"10.1371\/journal.pone.0071633","article-title":"Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease","volume":"8","author":"Abada","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.05.032_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/scan\/nsv093","article-title":"Theory of mind and empathy in preclinical and clinical Huntington's disease najia","volume":"11","author":"Adjeroud","year":"2015","journal-title":"Soc. Cogn. Affect. Neurosci. Theory"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pbb.2014.01.007","article-title":"Excitatory\/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster","volume":"118C","author":"Al\u00f2","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/cne.902460406","article-title":"Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study","volume":"246","author":"Cassell","year":"1986","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3389\/fnhum.2013.00468","article-title":"Making choice between competing rewards in uncertain vs. safe social environment: role of neuronal nicotinic receptors of acetylcholine","volume":"7","author":"Chabout","year":"2013","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1101\/lm.1676610","article-title":"The role of amygdala nuclei in the expression of auditory signaled two-way active avoidance in rats","volume":"17","author":"Choi","year":"2010","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nlm.2007.10.009","article-title":"Rigidity in social and emotional memory in the R6\/2 mouse model of Huntington's disease","volume":"89","author":"Ciamei","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0149-7634(97)00058-4","article-title":"Biological bases of anxiety","volume":"22","author":"Clement","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbr.2004.09.015","article-title":"Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze","volume":"158","author":"Cl\u00e9net","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02245598","article-title":"Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat","volume":"121","author":"Cole","year":"1995","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","article-title":"Mouse behavioral assays relevant to the symptoms of autism","volume":"17","author":"Crawley","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib13","series-title":"What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice","author":"Crawley","year":"2000"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13920","article-title":"Updating temporal expectancy of an aversive event engages striatal plasticity under amygdala control","author":"Dall\u00e9rac","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib15","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/scan\/nst029","article-title":"Neural correlates of impaired emotion processing in manifest Huntington's disease","volume":"9","author":"Dogan","year":"2014","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuron.2009.05.026","article-title":"Amygdala inhibitory circuits and the control of fear memory","volume":"62","author":"Ehrlich","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnbeh.2016.00204","article-title":"Impaired decision making and loss of inhibitory-control in a rat model of Huntington disease","volume":"10","author":"El Massioui","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0079-6123(08)61341-2","article-title":"The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat","volume":"99","author":"Faull","year":"1993","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nlm.2010.11.010","article-title":"Altered emotional and motivational processing in the transgenic rat model for Huntington's disease","volume":"95","author":"Faure","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(98)00736-7","article-title":"Striking changes in anxiety in Huntington's disease transgenic mice","volume":"805","author":"File","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib22","series-title":"Huntington's disease: a disorder of families","author":"Folstein","year":"1989"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2015.00099","article-title":"Social buffering suppresses fear-associated activation of the lateral amygdala in male rats: behavioral and neurophysiological evidence","volume":"9","author":"Fuzzo","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib25","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib26","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington \u2019 s Disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib27","series-title":"Huntington's Disease","author":"Harper","year":"1991"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib28","first-page":"1001","article-title":"Huntington's chorea on the island of Mauritius","volume":"60","author":"Hayden","year":"1981","journal-title":"S\u00a0Afr. Med. J."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.yfrne.2009.06.001","article-title":"Social buffering of the stress response: diversity, mechanisms, and functions","volume":"30","author":"Hennessy","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","article-title":"Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing","volume":"20","author":"Hickey","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.410340114","article-title":"Positron emission tomography measures of benzodiazepine receptors in Huntington's disease","volume":"34","author":"Holthoff","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1503\/jpn.100143","article-title":"Emotion recognition and experience in Huntington disease: a voxel-based morphometry study","volume":"36","author":"Ille","year":"2011","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2466\/pr0.103.1.77-87","article-title":"Social buffering in rat: prolactin attenuation of active interaction","volume":"103","author":"Insana","year":"2008","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature14188","article-title":"From circuits to behaviour in the amygdala","volume":"517","author":"Janak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-014-0072-z","article-title":"Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats","volume":"7","author":"Jiang","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2005.01.029","article-title":"Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis","volume":"1039","author":"Kennedy","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib38","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1111\/j.1460-9568.2007.05969.x","article-title":"Two types of social buffering differentially mitigate conditioned fear responses","volume":"26","author":"Kiyokawa","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0028-3908(02)00174-0","article-title":"GABAA receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem","volume":"43","author":"Kralic","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1358\/mf.2007.29.5.1117557","article-title":"Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs","volume":"29","author":"Kulkarni","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1531-8249(200005)47:5<644::AID-ANA13>3.0.CO;2-C","article-title":"Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography","volume":"47","author":"Kunig","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.biopsych.2009.12.002","article-title":"Sidman instrumental avoidance initially depends on lateral and basal amygdala and is constrained by central amygdala-mediated Pavlovian processes","volume":"67","author":"L\u00e1zaro-Mu\u00f1oz","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib43","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington\u2019 s disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archneur.55.10.1313","article-title":"Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders","volume":"55","author":"Litvan","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbr.2015.11.007","article-title":"Impulsivity trait in the early symptomatic BACHD transgenic rat model of Huntington disease","volume":"299","author":"Manfr\u00e9","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/cne.902080409","article-title":"Cytoarchitecture of the central amygdaloid nucleus of the rat","volume":"208","author":"McDonald","year":"1982","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0014-5793(91)80936-W","article-title":"Differential expression of GABAA receptor a-subunits in rat brain during development","volume":"286","author":"McKernan","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.physbeh.2016.05.001","article-title":"Social buffering enhances extinction of conditioned fear responses in male rats","volume":"163","author":"Mikami","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","article-title":"The GABA system in anxiety and depression and its therapeutic potential","volume":"62","author":"M\u00f6hler","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib50","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1523\/JNEUROSCI.2596-12.2013","article-title":"Active avoidance learning requires prefrontal suppression of amygdala-mediated defensive reactions","volume":"33","author":"Moscarello","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0076-6879(06)12008-X","article-title":"Imaging polyglutamine deposits in brain tissue","volume":"412","author":"Osmand","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington's disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib53","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1601-183X.2006.00295.x","article-title":"Social reward among juvenile mice","volume":"6","author":"Panksepp","year":"2007","journal-title":"Genes, Brain Behav."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pscychresns.2007.04.001","article-title":"Neural bases of dysphoria in early Huntington's disease","volume":"162","author":"Paradiso","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib55","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib56","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.32.12.1391","article-title":"Quantitative autoradiography of neurotransmitter receptors in Huntington disease","volume":"32","author":"Penney","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp.70.5.657","article-title":"Benzodiazepine receptor quantification in Huntington's disease with [123I]iomazenil and SPECT","volume":"70","author":"Pinborg","year":"2001","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-8993(79)90060-X","article-title":"Alterations in the benzodiazepine receptor of Huntington's diseased human brain","volume":"165","author":"Reisine","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1037\/h0024475","article-title":"Two-process learning theory: relationships between pavlovian conditioning and instrumental learning","volume":"74","author":"Rescorla","year":"1967","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/cdd.2010.127","article-title":"Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease","volume":"18","author":"Richards","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib62","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib63","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine Pathogenesis: emergence of unifying mechanisms for Huntington \u2019 s disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbr.2009.04.034","article-title":"Detection of early behavioral markers of Huntington's disease in R6\/2 mice employing an automated social home cage","volume":"203","author":"Rudenko","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(95)00153-N","article-title":"Regulation of anxiety by GABA a receptors in the rat amygdala","volume":"52","author":"Sanders","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib67","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuropharm.2007.09.011","article-title":"Neuroendocrine, behavioral and macrophage activity changes induced by picrotoxin effects in mice","volume":"54","author":"Stankevicius","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0166-2236(98)01265-X","article-title":"What is the amygdala","volume":"21","author":"Swanson","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","article-title":"Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport","volume":"40","author":"Szebenyi","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1037\/h0077817","article-title":"Fear and affiliation in domesticated male rats","volume":"95","author":"Taylor","year":"1981","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0306-4530(99)00019-0","article-title":"Behavioral and hormonal effects of partner familiarity in periadolescent rat pairs upon novelty exposure","volume":"24","author":"Terranova","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib72","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/brain\/awf179","article-title":"The distribution of structural neuropathology in pre-clinical Huntington \u00e2\u20ac\u2122 s disease","volume":"4","author":"Thieben","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib73","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.dcn.2011.05.007","article-title":"Evaluating the rewarding nature of social interactions in laboratory animals","volume":"1","author":"Trezza","year":"2011","journal-title":"Dev. Cogn. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib74","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in\u00a0vivo and in\u00a0vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Molucular Cell. Biol."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib75","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.34.9.1237","article-title":"Benzodiazepine and GABA receptors in early Huntington's disease","volume":"34","author":"Walker","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.05.032_bib76","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3758\/CABN.1.2.199","article-title":"Prolactin in rats is attenuated by conspecific touch in a novel environment","volume":"1","author":"Wilson","year":"2001","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/hbeh.2000.1600","article-title":"A\u00a0conspecific attenuates prolactin responses to open-field exposure in rats","volume":"38","author":"Wilson","year":"2000","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2017.05.032_bib78","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","article-title":"A\u00a0novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease","volume":"32","author":"Yu-Taeger","year":"2012","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817302575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817302575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T07:20:18Z","timestamp":1656055218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817302575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":78,"alternative-id":["S0028390817302575"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.05.032","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered reactivity of central amygdala to GABAAR antagonist in the BACHD rat model of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}